Edgewise Therapeutics (EWTX) corrects CMO’s 65K option grant price
Rhea-AI Filing Summary
Edgewise Therapeutics, Inc. reported an amended insider transaction for its CMO, Joanne M. Donovan. She received a grant of 65,000 stock options to purchase common stock at an exercise price of $43.56 per share, expiring on August 12, 2036. The company states this amendment corrects a clerical error in the originally reported exercise price. The options vest in equal monthly installments over four years starting on September 12, 2026, contingent on her continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Donovan Joanne M.
Role
CMO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 65,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 65,000 shares (Direct)
Footnotes (1)
- F1. 1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date.
Key Figures
Options Granted: 65,000 shares
Exercise Price: $43.56 per share
Expiration Date: 2036-08-12
+3 more
6 metrics
Options Granted
65,000 shares
Stock Option (Right to Buy) granted to CMO on 2026-08-12
Exercise Price
$43.56 per share
Corrected exercise price reflecting fair market value on grant date
Expiration Date
2036-08-12
Option expiration for 65,000-share grant
Underlying Shares
65,000 shares
Underlying common stock tied to the stock option grant
Vesting Rate
1/48 per month
1/48th of option shares vest monthly starting 2026-09-12
Vesting Start Date
2026-09-12
First vesting date contingent on continued service
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"The correct exercise price is $43.56, which reflects the fair market value"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"1/48th of the shares subject to the option vest each month"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-08-12"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did Edgewise Therapeutics (EWTX) report in this Form 4/A?
Edgewise Therapeutics reported a grant of 65,000 stock options to CMO Joanne M. Donovan. These options allow her to purchase common stock at a fixed exercise price, subject to long-term vesting and continued service.
What is the corrected exercise price of the EWTX stock options granted to Joanne M. Donovan?
The corrected exercise price is $43.56 per share. The amendment states this price reflects the fair market value of Edgewise Therapeutics common stock on the grant date and corrects a prior clerical reporting error.
How many Edgewise Therapeutics (EWTX) options does Joanne M. Donovan hold after this grant?
Following this transaction, Joanne M. Donovan holds 65,000 stock options related to this grant. These options are reported as directly owned and are subject to a multi-year vesting schedule starting in 2026.
When do Joanne M. Donovan’s EWTX stock options start vesting and over what period?
Vesting begins on September 12, 2026. According to the disclosure, 1/48th of the option shares vest each month thereafter, contingent on her continuing as a service provider through each vesting date.
When do the stock options granted to the EWTX CMO expire?
The reported stock options expire on August 12, 2036. After this expiration date, any unexercised options from this grant would no longer be exercisable under the terms described.
AI-generated analysis. How Rhea-AI works. Not financial advice.
